Anokion

Restoring normal IMMUNE TOLERANCE to treat autoimmune disease

General Information
Company Name
Anokion
Founded Year
-
Location (Offices)
Cambridge, United States +2
Founders / Decision Makers
Number of Employees
31
Industries
-
Funding Stage
-
Social Media

Anokion - Company Profile

Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.

Funding Rounds & Investors of Anokion (0)

View All

There is no investment information

Latest News of Anokion

View All

No recent news or press coverage available for Anokion.

Similar Companies to Anokion

View All
Delinia - Similar company to Anokion
Delinia Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus on enhancing regulatory T cells to maintain immune system balance.
Immune Tolerance Network - Similar company to Anokion
Immune Tolerance Network The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of
AbolerIS Pharma - Similar company to Anokion
AbolerIS Pharma The Immune system under control
Topas Therapeutics GmbH - Similar company to Anokion
Topas Therapeutics GmbH Providing meaningful therapeutic benefit to patients with autoimmune diseases.
Sonoma Biotherapeutics - Similar company to Anokion
Sonoma Biotherapeutics Leading the Next Frontier of Cell Therapy